Cytokinetics Hosts Webcast on Positive ACACIA-HCM Phase III Results
Cytokinetics held a hybrid webcast event in Munich with online participation, featuring an agenda that included opening remarks, expert panel discussion, and Q&A. Company representatives presented and replayed an encore presentation of the ACACIA-HCM Phase III results for aficamten, previously shared earlier in a hotline session at the Congress.